RESUMO
Background To evaluate the individual and combined effects of enterolactone, vitamin D, free testosterone, Chlamydia trachomatis and HPV-18 on the risk of prostate cancer in a large population-based biochemical material that combined three Nordic serum sample banks. Material and methods A joint cohort of 209 000 healthy men was followed using cancer registry linkages. From this cohort altogether 699 incident cases of prostate cancer were identified. Four controls were selected by incidence density sampling and matching for country, age and date of the blood sampling. Complete data for all investigated exposures was available for 483 eligible cases and 1055 eligible controls. Multivariate regression analyses were performed to investigate the solitary and combined effects. Results The solitary effects were small. Significantly increased risk [rate ratio 1.6 (95% CI 1.0-2.5)] was found in those seronegative for C. trachomatis infection. The joint effect in risk levels of enterolactone and vitamin D was antagonistic [observed rate ratio (RR) 1.4 (1.0-2.1), expected RR 2.0 (1.0-4.1)] as well as that of HPV-18 and C. trachomatis [observed RR 1.9 (0.8-4.5), expected RR 9.9 (1.1-87.0)]. Conclusion A large follow-up study combining data from several previously investigated exposures to investigate joint effects found no evidence that exposure to two risk factors would increase the risk of prostate cancer from that expected on basis of exposure to one risk factor. If anything, the results were consistent with antagonistic interactions.
Assuntos
Neoplasias da Próstata/etiologia , Vitamina D/sangue , 4-Butirolactona/análogos & derivados , 4-Butirolactona/sangue , Adulto , Bancos de Sangue/estatística & dados numéricos , Estudos de Casos e Controles , Infecções por Chlamydia/complicações , Chlamydia trachomatis/patogenicidade , Estudos de Coortes , Finlândia/epidemiologia , Papillomavirus Humano 18/patogenicidade , Humanos , Lignanas/sangue , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Noruega/epidemiologia , Infecções por Papillomavirus/complicações , Infecções por Papillomavirus/epidemiologia , Neoplasias da Próstata/epidemiologia , Fatores de Risco , Suécia/epidemiologia , Testosterona/sangueRESUMO
Due to the lack of rapid diagnostic tests, clinical features of Influenza C virus infections are poorly characterized. Respiratory infections in military recruits in eastern Finland were monitored between July 2004 and December 2005 in order to study the epidemiology and clinical picture of infections caused by this virus. Blood samples were obtained at entry and at the end of the military service, and during each episode of respiratory infection to measure antibody responses against 10 viral and 2 bacterial pathogens. If possible, sputum samples were collected during the acute phase of respiratory infection episodes. Symptoms of the episodes were recorded for comparison of the clinical picture caused by various infectious agents. Infection with influenza C virus was detected in 38 of 892 young men during their service. The virus usually caused a mild upper respiratory tract infection. Most typical clinical features of influenza C virus infection were cough, rhinitis, and hoarseness. A striking difference to infections caused by influenza A virus was the lack of fever. Influenza C virus is an important cause of a respiratory tract infection in army conscripts. Infections with this virus are usually mild but can be complicated in some cases.
Assuntos
Gammainfluenzavirus/isolamento & purificação , Influenza Humana/epidemiologia , Influenza Humana/patologia , Adolescente , Adulto , Anticorpos Antivirais/sangue , Finlândia/epidemiologia , Humanos , Influenza Humana/virologia , Masculino , Militares , Prevalência , Adulto JovemRESUMO
BACKGROUND: Chronic infections have been demonstrated to maintain low-grade systemic inflammation and associate with atherosclerosis. We studied the inflammation- and lipid homeostasis-related effects of Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) infections on the epididymal and inguinal adipose tissue (AT) transcriptomes and fatty acid distribution in apolipoprotein (apo) E-deficient mice. Chow-fed apoE-deficient mice were exposed to 1) chronic intranasal infection with C. pneumoniae (Cpn group), 2) recurrent intravenous infection with A. actinomycetemcomitans (Aa group), 3) a combination of both types of infection (Cpn + Aa group), or 4) infection with the vehicle (control group). Epididymal and inguinal AT gene expression was analyzed using an Illumina Mouse WG-6 v2.0 platform and quantitative PCR (QPCR). Microarray data were analyzed using Gene Ontology enrichment analysis. AT fatty acid analysis was performed using gas-liquid chromatography. RESULTS: The transcriptomics data revealed significant enrichment in inflammation-associated biological pathways in both AT depots derived from the Aa and Cpn + Aa treated mice compared with the control group. The proportion of saturated fatty acids was higher in the inguinal AT in Aa (p = 0.027) and Cpn + Aa (p = 0.009) groups and in the epididymal AT in Aa group (p = 0.003). The proportion of polyunsaturated fatty acids was significantly lower among all Aa-infected groups in both depots. Chronic Cpn infection displayed only minor effects on transcriptomics and fatty acids of the AT depots. CONCLUSIONS: Systemic infection with A. actinomycetemcomitans activates inflammation-related biological pathways and modulates cellular lipid homeostasis. The adverse changes in adipose tissues during chronic infection may promote atherosclerosis.
Assuntos
Tecido Adiposo/metabolismo , Aggregatibacter actinomycetemcomitans/fisiologia , Apolipoproteínas E/metabolismo , Chlamydophila pneumoniae/fisiologia , Ácidos Graxos/metabolismo , Animais , Apolipoproteínas E/deficiência , Apolipoproteínas E/genética , Aterosclerose/microbiologia , Aterosclerose/fisiopatologia , Ácidos Graxos Insaturados/metabolismo , Perfilação da Expressão Gênica , Masculino , Camundongos , Camundongos Knockout , RNA Mensageiro/metabolismo , TranscriptomaRESUMO
BACKGROUND: Pathogens such as Aggregatibacter actinomycetemcomitans (Aa) and Chlamydia pneumoniae (Cpn) associate with an increased risk for cardiovascular diseases by inducing inflammation. We hypothesized that the pathogens affect the vascular wall by disturbing cholesterol homeostasis and endothelial function. METHODS: Aa- and Cpn-infections were induced in apoE-deficient mice by intravenous and intranasal applications, respectively. Cholesterol efflux from mouse peritoneal macrophages to apo(lipoprotein)A-I was assessed. The efflux capacity of mouse sera as acceptors of cholesterol from RAW264.7-macrophages was determined. Additionally, endothelial function was studied by following the relaxation capacity of rat mesenteric arteries after incubation in the conditioned culture media of the peritoneal macrophages isolated from the mice. RESULTS: Infection increased serum phospholipid transfer protein (PLTP) and lipopolysaccharide (LPS) activity, as well as serum amyloid A (SAA) and TNF-α concentrations. Peritoneal macrophages of mice with Aa-infection showed increased cholesterol uptake and reduced cholesterol efflux. Sera of Cpn and Cpn + Aa-infected mice had reduced cholesterol efflux capacity from RAW264.7-macrophages. Conditioned macrophage medium from mice with chronic C. pneumoniae infection induced endothelial dysfunction. Additionally, concentrations of serum adhesion molecules, intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM) in Cpn-groups and E-selectin in Cpn + Aa-group, were elevated. The serum markers of endothelial function correlated positively with SAA. CONCLUSIONS: Aa- and Cpn-infections may generate proatherogenic changes in the vascular wall by affecting the macrophage cholesterol homeostasis and endothelial function.
Assuntos
Apolipoproteínas E/deficiência , Chlamydophila pneumoniae/patogenicidade , Colesterol/metabolismo , Macrófagos/metabolismo , Macrófagos/microbiologia , Pasteurellaceae/patogenicidade , Animais , Infecções por Chlamydophila/microbiologia , Infecções por Chlamydophila/patologia , Meios de Cultivo Condicionados , Modelos Animais de Doenças , Células Endoteliais/fisiologia , Homeostase , Lipopolissacarídeos/sangue , Masculino , Camundongos , Camundongos Knockout , Infecções por Pasteurellaceae/microbiologia , Infecções por Pasteurellaceae/patologia , Proteínas de Transferência de Fosfolipídeos/sangue , Ratos , Soro/química , Proteína Amiloide A Sérica/análise , Fator de Necrose Tumoral alfa/sangueRESUMO
BACKGROUND: Rapamycin, an immunosuppressive and antiproliferative drug, is used to prevent neointima formation to reduce the risk of in-stent restenosis with rapamycin eluting-stents. Chronic infection of Chlamydia pneumoniae has been associated with cardiovascular diseases, and could play an important role in the mechanism of restenosis. We examined the effect of rapamycin on the growth of C. pneumoniae in cell cultures. METHODS: HL cell monolayers were inoculated with C. pneumoniae CWL029 or C. trachomatis L2. Different concentrations of rapamycin were present in the culture medium continuously or for 8-hour periods. After incubation the infected cells were repassaged to fresh HL cell monolayers and incubated in the medium without rapamycin. The newborn inclusions from both passages were checked by fluorescent microscope or electron microscope. RESULTS: The presence of 23 microg/ml rapamycin restricted over 90% of the growth of C. pneumoniae. Continuous presence of 11 microg/ml rapamycin inhibited the growth of C. pneumoniae up to 80% and caused smaller inclusions, fewer chlamydial particles and fewer matured EBs. 11 microg/ml rapamycin presented in first passage caused the reduction of C. pneumoniae to 57% at first passage and 24% at second passage. CONCLUSIONS: Sufficient rapamycin can inhibit the growth of C. pneumoniae effectively, but it should be applied at the early stage of the chlamydial infections. Rapamycin eluting-stents can induce a high enough local concentration of rapamycin. This provides a possibility for us to suppose that the beneficial effect of rapamycin in preventing in-stent restenosis might partly be explained by its inhibitory effects on the growth of C. pneumoniae.
Assuntos
Antibacterianos/farmacologia , Chlamydophila pneumoniae/efeitos dos fármacos , Sirolimo/farmacologia , Antibacterianos/administração & dosagem , Linhagem Celular , Chlamydia trachomatis/efeitos dos fármacos , Relação Dose-Resposta a Droga , Stents Farmacológicos , Humanos , Testes de Sensibilidade Microbiana , Microscopia Eletrônica de Transmissão , Microscopia de Fluorescência , Sirolimo/administração & dosagem , Fatores de TempoRESUMO
Periodontitis and Chlamydia pneumoniae infection are independent risk factors for cardiovascular diseases. The aim of this study was to investigate the effect of C. pneumoniae and Aggregatibacter actinomycetemcomitans infection on hepatic inflammation and lipid homeostasis of apolipoprotein E-deficient mice. Mice were infected with viable C. pneumoniae intranasally three times for chronic infection or once for acute infection. Viable A. actinomycetemcomitans was administered 10 times intravenously alone or in concert with C. pneumoniae. Hepatic alterations were assessed by histochemistry, lipid quantification, and fatty acid profile analysis. The RNA expression levels and the presence of pathogens in the livers and lungs were detected by quantitative real-time PCR. Both pathogens were detected in the livers of the infected animals. Chronic C. pneumoniae infection induced marked changes in hepatic lipid homeostasis. A. actinomycetemcomitans infection resulted in inflammatory cell infiltration into the liver, accompanied by elevated hepatic RNA expression levels of inflammation-related genes and higher serum amyloid A and lipopolysaccharide concentrations. Our results indicate that proatherogenic pathogens infect the liver, causing proinflammatory alterations and lipid disturbances. This infection may maintain chronic systemic inflammation attributable to atherogenesis.
Assuntos
Apolipoproteínas/deficiência , Infecções por Chlamydophila/patologia , Ácidos Graxos/metabolismo , Hepatite/microbiologia , Hepatite/patologia , Infecções por Pasteurellaceae/patologia , Animais , Chlamydophila pneumoniae/patogenicidade , Lipopolissacarídeos/sangue , Fígado/microbiologia , Fígado/patologia , Pulmão/microbiologia , Pulmão/patologia , Masculino , Camundongos , Pasteurellaceae/patogenicidade , Proteína Amiloide A Sérica/análiseRESUMO
OBJECTIVES: We sought to examine the role of complement component C4 deficiencies on the effect of antibiotic treatment in patients with acute coronary syndrome (ACS). DESIGN: Patients with ACS (n=144) were randomly divided to receive a three-month treatment of clarithromycin or placebo and followed for major adverse coronary and cerebrovascular events (MACCEs) for 404.5 median days (range 138-924 days). The primary results indicated that clarithromycin prevented recurrent cardiovascular attacks. For the present study we performed serum C4 allotyping of C4A and C4B. The clarithromycin response was reanalyzed taking into account the deficiencies in the C4 allotypes. RESULTS: The prevalence of C4A deficiency, C4B deficiency or these combined were 29.2% (42/144), 39.6% (57/144) and 66.0% (95/144), respectively. In patients with C4 deficiencies clarithromycin treatment resulted in a reduced number of MACCEs and the best cumulative survival as compared with the placebo group (MACCE 18.8% versus 39.1%, respectively; Log rank test, p=0.015). CONCLUSIONS: Only patients with ACS and C4 deficiencies seem to benefit from antibiotic treatment. This may explain the controversial results of secondary prevention trials of coronary artery disease and possibly serve as a pharmacogenomic marker for clarithromycin treatment.
Assuntos
Síndrome Coronariana Aguda/tratamento farmacológico , Antibacterianos/uso terapêutico , Claritromicina/uso terapêutico , Complemento C4/deficiência , Síndrome Coronariana Aguda/etiologia , Síndrome Coronariana Aguda/metabolismo , Idoso , Chlamydophila pneumoniae/isolamento & purificação , Complemento C4/genética , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Chlamydia pneumoniae has been associated with cardiovascular diseases and has been shown by different methods to be present in atherosclerotic lesions. However, not all studies have found C. pneumoniae in atherosclerotic tissues. We compared polymerase chain reaction (PCR) methods, in situ hybridization (ISH), and measurement of chlamydial lipopolysaccharide (cLPS) by enzyme immunoassay (EIA) from homogenized atherosclerotic tissue in the detection of C. pneumoniae. In a study population of 110 patients with carotid artery disease, cLPS was found in 22.2%, and DNA by PCR was found in 34.3% and by ISH in 39.4% of the samples. Poor repeatability was shown to complicate PCR, and the technical problems inherent in ISH were not insignificant. In contrast, the cLPS EIA test was fast and easy to perform. If the sensitivity could be increased, for example, by testing multiple tissue pieces, cLPS EIA might provide a standardized commercial method for the detection of chlamydia in tissue samples, and it, thus, merits further characterization and validation in different patient populations.
Assuntos
Estenose das Carótidas/microbiologia , Chlamydophila pneumoniae/isolamento & purificação , Técnicas Imunoenzimáticas/métodos , Hibridização In Situ/métodos , Reação em Cadeia da Polimerase/métodos , Idoso , Feminino , Humanos , Lipopolissacarídeos/análise , Masculino , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
The effects of the selective cyclooxygenase (COX) inhibitors SC-560 and PTPBS were studied in Chlamydia pneumoniae-infected HL cell cultures. Chlamydia pneumoniae growth and viability were assessed by quantifying inclusions and re-passages. COX-1 and COX-2 mRNA expression in HL cells during chlamydial infection was quantified with real-time polymerase chain reaction. SC-560 (10 microg/mL) and PTPBS (18 microg/mL) completely inhibited the growth of C. pneumoniae and the effect was dose-dependent between 4-9 microg/mL and 2-16 microg/mL, respectively. Inclusion size was reduced from 11.5+/-1.3 microm to 1.9+/-0.7 microm in the presence of the drugs. Removing the drugs returned the size to normal and increased the number of inclusions. Selective COX inhibitors appear to have a chlamydiostatic but not chlamydiacidic effect; they inhibit the growth of C. pneumoniae in vitro but do not prevent infection or eradicate C. pneumoniae from host cells.
Assuntos
Antibacterianos/farmacologia , Chlamydophila pneumoniae/efeitos dos fármacos , Inibidores de Ciclo-Oxigenase/farmacologia , Linfócitos/microbiologia , Linhagem Celular , Chlamydophila pneumoniae/crescimento & desenvolvimento , Ciclo-Oxigenase 1/biossíntese , Ciclo-Oxigenase 2/biossíntese , Relação Dose-Resposta a Droga , Perfilação da Expressão Gênica , Humanos , Corpos de Inclusão/microbiologia , Viabilidade Microbiana , PirazóisRESUMO
To study the respiratory and physical health of young men, 224 asthmatic and 668 non-asthmatic military conscripts were recruited from the intake groups of July 2004 and January 2005 in Kajaani, Finland. Factors affecting respiratory health were elicited by a questionnaire at the beginning of the service, and results of high sensitive C-reactive protein (hsCRP) determination, peak expiratory flow (PEF), and 12-minute running test were collected at the beginning and the end of the service. Respiratory infections were diagnosed by a study physician. Upon entering military service, asthmatics had frequent exercise- and cold-related asthma symptoms (69.6% and 76.3%), and 48% of them had no medication for asthma. At the beginning, 25.8% of asthmatics and 19.1% of non-asthmatics had a poor result of less than 2,200 m (p = 0.05) in the 12-minute running test, and after 180 to 362 days of service, the corresponding percentages were 11.7% and 9.7% (p = 0.434). The levels of hsCRP, a marker of low-grade systemic inflammation, decreased significantly among both asthmatics, 1.5 (p = 0.001), and non-asthmatics, 1.6 mg/L (p < 0.001). Asthmatic men had 0.2 and non-asthmatics 0.1 respiratory infections per month (p < 0.001). In summary, asthmatic conscripts can enhance their physical fitness by training similarly to non-asthmatic ones. Their levels of hsCRP also decrease.
Assuntos
Asma/sangue , Proteína C-Reativa/metabolismo , Aptidão Física , Corrida , Adenoidectomia , Adolescente , Adulto , Asma/fisiopatologia , Índice de Massa Corporal , Finlândia , Humanos , Masculino , Militares , Pico do Fluxo Expiratório , Infecções Respiratórias/sangue , Infecções Respiratórias/fisiopatologia , Rinite/sangue , Rinite/fisiopatologia , TonsilectomiaRESUMO
BACKGROUND AND OBJECTIVE: Acute respiratory tract infections are the leading cause of missed service days among military conscripts. The aim of this study was to identify factors that possibly predicted and contributed to frequent respiratory tract infections among military conscripts. METHODS: Data on episodes of respiratory illness were collected during the 180-day period of military service in Kajaani, Finland, between July 2004 and July 2005. RESULTS: There were 518 military conscripts recruited, 124 of whom had a diagnosis of asthma. Conscripts with frequent (three or more) infections were more often atopic or suffered from allergic rhinitis or asthma. Overweight (BMI >/= 25 kg/m(2)) and previous respiratory tract infections were the two independent risk factors for frequent respiratory infections. Overall, 4.8% of those who had no risk factors, 10. 3% of those with one risk factor and 35.7% of those with two risk factors suffered from frequent respiratory infections (P for trend < 0.001). CONCLUSIONS: Overweight (BMI >/= 25 kg/m(2)) and previous respiratory tract infections are risk factors for frequent respiratory tract infections in young men during military service.
Assuntos
Militares , Sobrepeso/epidemiologia , Infecções Respiratórias/epidemiologia , Adolescente , Adulto , Índice de Massa Corporal , Proteína C-Reativa/análise , Finlândia , Humanos , Masculino , Prevalência , Recidiva , Fatores de Risco , Estações do AnoRESUMO
Acute Chlamydia pneumoniae infection may initiate asthma or worsen asthmatic symptoms. In crowded conditions, such as military service, young men are susceptible to respiratory infections, including C. pneumoniae. We recruited 127 asthmatic and 391 nonasthmatic military conscripts, followed up their respiratory tract infections and the kinetics of serum C. pneumoniae antibodies, and assessed the association between C. pneumoniae and asthma during 6 months of military service in 2 intake groups. During the 6-month period, in the July intake group, IgG antibody prevalence decreased from 60.3% to 43.8% in asthmatic and from 55.6% to 22.6% in nonasthmatic conscripts. In the January intake group, IgG antibody prevalence increased from 38.3% to 48.4% in asthmatic and from 37.2% to 43% in nonasthmatic recruits. IgG and IgA antibodies persisted more often in the asthmatic groups. In conclusion, the prevalence of IgG antibodies showed seasonal variation. Military recruits seem to be most vulnerable to C. pneumoniae infections during the period from January to June. The antibody titer changes were more rapid than previously thought.
Assuntos
Anticorpos Antibacterianos/sangue , Asma/complicações , Infecções por Chlamydophila/complicações , Chlamydophila pneumoniae/imunologia , Militares , Infecções Respiratórias/complicações , Adolescente , Adulto , Asma/imunologia , Infecções por Chlamydophila/imunologia , Infecções por Chlamydophila/microbiologia , Finlândia/epidemiologia , Humanos , Imunoglobulina G/sangue , Masculino , Prevalência , Infecções Respiratórias/imunologia , Infecções Respiratórias/microbiologia , Estações do AnoRESUMO
Glycosaminoglycans are known to participate in the attachment of several chlamydial strains. We studied the effect of heparin, enoxaparin, low-molecular-weight heparin, chondroitin sulfate A, and heparinase I on the infectivity of Chlamydia pneumoniae strain CWL029 and two Finnish isolates, Kajaani 7 and Parola, in an HL cell line which is epithelial in origin. Two Chlamydia trachomatis strains, L2 and E, were used for comparison. The infectivity of all C. pneumoniae strains and C. trachomatis serovar E was inhibited not only by heparin derivatives but also by chondroitin sulfate A and heparinase treatment. Treatment of host cells with heparin derivatives and heparinase was also inhibitory. Different chlamydial strains and species seem, however, to vary in their ability to use heparin in their attachment to host cells.
Assuntos
Chlamydophila pneumoniae/efeitos dos fármacos , Células Epiteliais/microbiologia , Fibroblastos/microbiologia , Glicosaminoglicanos/farmacologia , Animais , Linhagem Celular , Chlamydia trachomatis/metabolismo , Chlamydophila pneumoniae/genética , Chlamydophila pneumoniae/metabolismo , Células Epiteliais/metabolismo , Fibroblastos/metabolismo , Humanos , CamundongosRESUMO
Lipopolysaccharide (LPS) is an exdotoxin found in the outer membrane of gram-negative bacteria. In circulation, LPS is bound by LPS-binding protein (LBP), which participates in cell activation by transferring LPS to CD14 and Toll-like receptor 4. A high LPS concentration may give rise to an exaggerated immune response, which may lead to septic shock during septicemia. However, LBP also neutralizes and removes LPS by transferring it to plasma lipoproteins. Recently, the presence of an amino acid-changing polymorphism in the LBP gene was reported, which, in men, was associated with sepsis and its severity and with myocardial infarction. Here, we describe a new LightCycler real-time PCR method for genotyping this LBP C(1341)-->T (Leu(436)-->Phe) polymorphism. In our study population of 393 Finnish blood donors, the genotype frequencies were: 86% TT, 13% CT and 1% CC.
Assuntos
Proteínas de Fase Aguda/genética , Proteínas de Transporte/genética , Glicoproteínas de Membrana/genética , Polimorfismo Genético , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Feminino , Frequência do Gene , Genótipo , Humanos , MasculinoRESUMO
The lack of specific tests for the diagnosis of chronic Chlamydia pneumoniae infection has led to the use of enzyme immunoassay (EIA) instead of the gold standard, that is, microimmunofluorescence (MIF), in the measurement of C. pneumoniae antibodies. We assessed the predictive values of C. pneumoniae antibody levels and seroconversions measured by MIF and EIA for coronary events in the prospective Helsinki Heart Study. Sera from 239 cases with coronary events and 239 controls were available at the baseline and data from 210 cases and 211 controls before and after the event. The agreement between MIF and EIA antibody levels was best in high antibody titers. In conditional logistic regression analysis, only high IgA MIF titers (>/=40) at the baseline predicted future coronary events, and the participants with MIF seroconversion between consecutive sera had a higher (nonsignificant) risk for coronary events than the controls. The difference in the kinetics of EIA and MIF antibodies demonstrated that MIF should remain the gold standard.
Assuntos
Anticorpos Antibacterianos/sangue , Doenças Cardiovasculares/microbiologia , Infecções por Chlamydia/imunologia , Chlamydophila pneumoniae/imunologia , Imunoglobulina G/sangue , Complexo Antígeno-Anticorpo/sangue , Complexo Antígeno-Anticorpo/química , Doenças Cardiovasculares/sangue , Infecções por Chlamydia/microbiologia , Método Duplo-Cego , Imunofluorescência , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Técnicas Imunoenzimáticas , Estudos Prospectivos , Ensaios Clínicos Controlados Aleatórios como Assunto , Análise de RegressãoRESUMO
Chlamydia pneumoniae causes respiratory tract infections. It has a tendency to cause persistent infections, which have been associated with several chronic diseases (e.g., atherosclerosis). At present, there is no reliable method for the diagnosis of chronic C. pneumoniae infection. We developed a novel enzyme immunoassay (EIA) for the quantification of chlamydial lipopolysaccharide (cLPS) in human serum. Serum cLPS was solubilized with detergent and then captured by LPS-binding protein (LBP). LBP-LPS complexes were bound to the solid phase with anti-cLPS monoclonal antibody, and the bound complexes were detected with anti-LBP antibodies. The new method was used to quantify serum cLPS in acute coronary syndrome (ACS) patients (n = 102) and their healthy controls. cLPS was detected in 77.5% of ACS patients and in 52% of controls (P < .001) with geometric mean concentrations of 1.87 and 0.61 microg/mL (P < .001), respectively. The novel cLPS EIA method will provide a potential diagnostic tool for C. pneumoniae infection.
Assuntos
Proteínas de Fase Aguda/imunologia , Proteínas de Transporte/imunologia , Chlamydophila pneumoniae/química , Técnicas Imunoenzimáticas , Lipopolissacarídeos/sangue , Glicoproteínas de Membrana/imunologia , Anticorpos Antibacterianos/análise , Anticorpos Antibacterianos/sangue , HumanosRESUMO
Endothelial dysfunction plays an important role in the development of atherosclerosis. Previous studies have shown that inoculation with Chlamydia pneumoniae contributes to atherosclerotic development in rabbits and hypercholesterolaemic mice and causes endothelial dysfunction in apolipoprotein E-deficient mice. The effect of acute C. pneumoniae infection on endothelial function in normocholesterolaemic C57BL/6J mice was studied by measuring the force of contraction of the descending aorta after noradrenaline stimulation and in response to methacholine-induced relaxation. In addition, the effects of the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME) and the cyclooxygenase inhibitor diclofenac on relaxation were assessed. Pre-treatment of the aortas with L-NAME decreased the relaxation response in both the infected and uninfected groups and no significant difference was detected between these groups, whereas diclofenac significantly attenuated the relaxation response only in the infected animals. In conclusion, infection shifted the balance of endothelium-derived relaxing factors from nitric oxide towards vasorelaxing prostanoids in C57BL/6J mice.
Assuntos
Aorta Torácica/fisiopatologia , Infecções por Chlamydophila/fisiopatologia , Chlamydophila pneumoniae , Prostaglandinas/metabolismo , Vasodilatação , Animais , Aorta Torácica/efeitos dos fármacos , Inibidores de Ciclo-Oxigenase/farmacologia , Diclofenaco/farmacologia , Modelos Animais de Doenças , Inibidores Enzimáticos/farmacologia , Feminino , Cloreto de Metacolina/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico/metabolismo , Norepinefrina/farmacologia , Prostaglandinas/farmacologia , Vasoconstritores/farmacologia , Vasodilatação/efeitos dos fármacosRESUMO
BACKGROUND: Given the role of chronic infections, autoimmunity, and inflammation in atherosclerosis, we studied the joint effect of chronic Chlamydia pneumoniae infection, persistently elevated human heat-shock protein 60 (hHsp60) antibodies, and C-reactive protein (CRP) on coronary risk. METHODS AND RESULTS: The participants for this prospective nested case-control study were obtained from the Helsinki Heart Study, during which 241 nonfatal myocardial infarctions or coronary deaths occurred among 4081 dyslipidemic middle-aged men. Serum samples taken at baseline and 3 to 6 months before the coronary events that occurred during the 8.5-year period were analyzed for antibodies to C pneumoniae and hHsp60 and the CRP concentration. Compared with persistently low levels, the risk of coronary events was 2-fold for persistently elevated immunocomplex (IC)-bound and/or serum IgA antibodies to C pneumoniae (OR, 1.96; 95% CI, 1.14 to 3.36) and also for serum IgA antibodies to hHsp60 (OR, 2.11; 95% CI, 1.08 to 4.13). The risks associated with elevated antibodies were much higher when CRP was also elevated. Compared with low or transiently elevated levels, the risk of coronary events, with adjustment for age and smoking, was 4.5-fold for persistently elevated CRP and C pneumoniae IC/IgA antibodies together (OR, 4.47; 95% CI, 1.84 to 10.83) and was similar for CRP and hHsp60 IgA antibodies together (OR, 4.36; 95% CI, 1.53 to 12.39). CONCLUSIONS: Persistently but not transiently elevated C pneumoniae IC/IgA and hHsp60 IgA antibodies, especially when present together with an elevated CRP level, predicted coronary events.
Assuntos
Autoimunidade , Infecções por Chlamydophila/imunologia , Doença das Coronárias/imunologia , Inflamação , Autoanticorpos/sangue , Proteína C-Reativa/análise , Estudos de Casos e Controles , Chaperonina 60/imunologia , Infecções por Chlamydophila/epidemiologia , Doença Crônica , Comorbidade , Doença das Coronárias/epidemiologia , Doença das Coronárias/microbiologia , Finlândia/epidemiologia , Humanos , Imunoglobulina A/sangue , Inflamação/imunologia , Inflamação/microbiologia , Masculino , Pessoa de Meia-Idade , Razão de Chances , Estudos Prospectivos , Medição de RiscoRESUMO
OBJECTIVE: We assessed the risk of prostate cancer by exposure to Chlamydia trachomatis. METHOD: Seven hundred thirty eight cases of prostate cancer and 2,271 matched controls were identified from three serum sample banks in Finland, Norway, and Sweden by linkage to the population based cancer registries. RESULTS: A statistically significant inverse association (odds ratio, 0.69; 95% confidence interval, 0.51-0.94) was found. It was consistent by different serotypes and there was a consistent dose-response relationship. CONCLUSION: C. trachomatis infection is not likely to increase the risk of prostate cancer. Whether the inverse relationship is true or due to difficulties in measuring the true exposure in prostatic tissue by serology, confounders or other sources of error remain open.